Article information
Full text is only available in PDF
Bibliografía
[1.]
J.C. Bestall, E.A. Paul, R. Garrod, R. Garnham, P.W. Jones, J.A. Wedzicha.
Usefulness of the Medical Research Council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary disease.
Thorax, 54 (1999), pp. 581-586
[2.]
J.M. Marín.
Manifestaciones clínicas: la disnea y su importancia en el paciente con EPOC.
Arch Bronconeumol, 37 (2001), pp. 8-13
[3.]
J.M. Marín, S.J. Carrizo, M. Gascón, A. Sánchez, B. Gallego, B.R. Celli.
Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 163 (2001), pp. 1395-1399
[4.]
M.J. Belman, W.C. Botnick, J.W. Shin.
Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 153 (1996), pp. 967-975
[5.]
R. Debigaré, C.H. Cõté, F. Maltais.
Peripheral muscle wasting in Chronic Obstructive Pulmonary Disease. Clinical relevance and mechanisms.
Am J Respir Crit Care Med, 164 (2001), pp. 1712-1717
[6.]
American Thoracic Society.
Dyspnea: mechanisms, assessment and management: a consensus statement.
Am J Respir Crit Care Med, 159 (1999), pp. 321-340
[7.]
H.C.F. McCathie, S.H. Spence, R.L. Tate.
Adjustement to chronic obstructive pulmonary disease: the importance of psychological factors.
Eur Respir J, 19 (2002), pp. 47-53
[8.]
P.W. Jones.
Health status measurement in chronic obstructive pulmonary disease.
Thorax, 56 (2001), pp. 880-887
[9.]
P.W. Jones, F.H. Quirk, C.M. Baveystock, P. Littlejohns.
A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire.
Am Rev Respir Dis, 145 (1992), pp. 1321-1327
[10.]
T. Hajiro, K. Nishimura, M. Tsukino, A. Ikeda, T. Oga, T. Izumi.
A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD.
Chest, 116 (1999), pp. 1632-1637
[11.]
M. Ferrer, J. Alonso.
Medición de la calidad de vida en los pacientes con EPOC.
Arch Bronconeumol, 37 (2001), pp. 20-26
[12.]
G.H. Guyatt, L.B. Berman, M. Townsend, S.O. Pugsley, L.W. Chambers.
A measure of quality of life for clinical trials in chronic lung disease.
Thorax, 42 (1987), pp. 773-778
[13.]
R. Güell, P. Casan, M. Sangenís, F. Morante, J. Belda, G.H. Guyatt.
Quality of life in patients with chronic respiratory disease: the Spanish version of the Chronic Respiratory Questionnaire.
Eur Respir J, 11 (1998), pp. 55-60
[14.]
M. Ferrer, J. Alonso, L. Prieto, V. Plaza, E. Monsó, R. Marrades, et al.
Validity and reliability of the St. George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example.
Eur Respir J, 9 (1996), pp. 1160-1166
[15.]
M. Ferrer, J. Alonso, J. Morera, R.M. Marrades, A. Khalaf, M.C. Aguar, et al.
Chronic obstructive pulmonary disease stage and health- related quality of life.
Ann Intern Med, 127 (1997), pp. 1072-1079
[16.]
J.E.A. Williams, S.J. Singh, L. Sewell, G.H. Guyatt, M.D.L. Morgan.
Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR).
Thorax, 56 (2001), pp. 954-959
[17.]
M. Ferrer, C. Villasante, J. Alonso, V. Sobradillo, R. Gabriel, G. Vilagut, et al.
Interpretation of quality of life scores from the St. George's Respiratory Questionnaire.
Eur Respir J, 19 (2002), pp. 405-413
[18.]
R. Harper, J.E. Brazier, J.C. Waterhouse, S.J. Walters, N.M.B. Jones, P. Howard.
Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting.
Thorax, 52 (1997), pp. 879-887
[19.]
T. Hajiro, K. Nishimura, M. Tsukino, A. Ikeda, H. Koyama, T. Izumi.
Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 157 (1998), pp. 785-790
[20.]
M. Rutten-van Mölken, B. Roos, J.A. Van Noord.
An empirical comparison of the St. George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting.
Thorax, 54 (1999), pp. 995-1003
[21.]
G.H. Guyatt, D.R. King, D.H. Feeny, D. Stubbing, R.S. Goldstein.
Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation.
J Clin Epidemiol, 52 (1999), pp. 187-192
[22.]
R. Jaeschke, J. Singer, G.H. Guyatt.
Measurement of health status. Ascertaining the minimal clinically important difference.
Control Clin Trials, 10 (1989), pp. 407-415
[23.]
P.W. Jones.
Interpreting thresholds for a clinically significant change in health status in asthma and COPD.
Eur Respir J, 19 (2002), pp. 398-404
[24.]
T. Hajiro, K. Nishimura.
Minimal clinically significant difference in health status: the thorny path of health status measures? [editorial].
Eur Respir J, 19 (2002), pp. 390-391
[25.]
P.W. Jones, T.K. Bosh.
Quality of life changes in COPD patients treated with salmeterol.
Am J Respir Crit Care Med, 155 (1997), pp. 1283-1289
[26.]
R. Dahl, L.A.P.M. Greefhorst, D. Nowak, V. Nonikov, A.M. Byrne, M.H. Thomson, et al.
Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 164 (2001), pp. 778-784
[27.]
W. Vincken, J.A. Van Noord, A.P.M. Greefhorst, T.A. Bantje, S. Kesten, L. Korducki, et al.
Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium.
Eur Respir J, 19 (2002), pp. 209-216
[28.]
R. Casaburi, D.A. Mahler, P.W. Jones, A. Wanner, G. San Pedro, R.L. Zu- Wallack, et al.
A long term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.
Eur Respir J, 19 (2002), pp. 217-224
[29.]
Y. Lacasse, E. Wong, G.H. Guyatt, D. King, D.J. Cook, R.S. Goldstein.
Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease.
Lancet, 348 (1996), pp. 1115-1119
[30.]
T.L. Griffiths, M.L. Burr, I.A. Campbell, V. Lewis-Jenkins, J. Mullins, K. Shiels, et al.
Results of a year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial.
Lancet, 355 (2000), pp. 362-368
[31.]
R. Güell, P. Casan, J. Belda, M. Sangenís, F. Morante, G.H. Guyatt, et al.
Long-term effects of outpatient rehabilitation of COPD: a randomized trial.
Chest, 117 (2000), pp. 976-983
Copyright © 2002. Sociedad Española de Neumología y Cirugía Torácica
